Pathway to discovery in rare disease
Sanofi researchers are investigating a metabolic hub that plays a key role in three classes of rare disease
The Fight against COVID-19
As the pandemic continues, Sanofi is at the forefront of vaccine development, while carrying on the daily business of making and delivering medicines for patients
Supporting People with Cancer during COVID-19
Despite the challenges caused by COVID-19, Sanofi continues to support the patient communities it serves—including the cancer community
There Is No Health Without Mental Health
Sanofi and its partners have been working for more than ten years to promote access to healthcare for patients with mental disorders in developing countries
Third Quarter Results 2020
Sanofi’s financial results will be published on October 29, providing a look at its business performance and the execution of its strategy
-
Press releases2020-10-16MMMM DD YYYYCHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis